MantaBio
Developer of an automated, cartridge-based molecular monitoring system for rapid detection of viable microorganisms and viruses. The company’s platform integrates sample concentration and preparation, nucleic acid purification, and qPCR-based multiplex detection to provide near-line point-of-need results (targeting ~2 hours) for biopharmaceutical manufacturing and other testing environments.
Industries
Nr. of Employees
small (1-50)
MantaBio
48 Dunham Ridge Road, Suite 4900, Beverly, MA, 01915 USA
Products
MantaVision System
An automated, cartridge-based molecular monitoring instrument that concentrates and processes liquid samples, performs nucleic acid extraction and multiplex qPCR, and provides semi-quantitative digital readouts for presence/absence of viable microorganisms and selected viruses in under 2 hours.
MantaVision System
An automated, cartridge-based molecular monitoring instrument that concentrates and processes liquid samples, performs nucleic acid extraction and multiplex qPCR, and provides semi-quantitative digital readouts for presence/absence of viable microorganisms and selected viruses in under 2 hours.
Expertise Areas
- Automated microbial detection
- Bioprocess and near-line monitoring
- qPCR-based molecular diagnostics
- Microfluidic consumable design
Key Technologies
- Real-time quantitative PCR (qPCR)
- Microfluidics (single-use cartridges)
- Sample concentration and filter-based capture
- Automated nucleic acid extraction
News & Updates
Raised $2.5 million in seed funding to advance development of an automated platform for microbial contamination detection in biologics manufacturing.
Company founded in January 2025.
Raised $2.5 million in seed funding to advance development of an automated platform for microbial contamination detection in biologics manufacturing.
Company founded in January 2025.